539 related articles for article (PubMed ID: 32583078)
1. Diabetes increases the mortality of patients with COVID-19: a meta-analysis.
Wu ZH; Tang Y; Cheng Q
Acta Diabetol; 2021 Feb; 58(2):139-144. PubMed ID: 32583078
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis.
Singh AK; Gillies CL; Singh R; Singh A; Chudasama Y; Coles B; Seidu S; Zaccardi F; Davies MJ; Khunti K
Diabetes Obes Metab; 2020 Oct; 22(10):1915-1924. PubMed ID: 32573903
[TBL] [Abstract][Full Text] [Related]
3. Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 (COVID-19) infection.
Wu J; Zhang J; Sun X; Wang L; Xu Y; Zhang Y; Liu X; Dong C
Diabetes Obes Metab; 2020 Oct; 22(10):1907-1914. PubMed ID: 32496012
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients.
Silverio A; Di Maio M; Citro R; Esposito L; Iuliano G; Bellino M; Baldi C; De Luca G; Ciccarelli M; Vecchione C; Galasso G
BMC Cardiovasc Disord; 2021 Jan; 21(1):23. PubMed ID: 33413093
[TBL] [Abstract][Full Text] [Related]
5. Detrimental effect of diabetes and hypertension on the severity and mortality of COVID-19 infection: A multi-center case-control study from India.
Jayaswal SK; Singh S; Malik PS; Venigalla SK; Gupta P; Samaga SN; Hota RN; Bhatia SS; Gupta I
Diabetes Metab Syndr; 2021; 15(5):102248. PubMed ID: 34412000
[TBL] [Abstract][Full Text] [Related]
6. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis.
Kumar A; Arora A; Sharma P; Anikhindi SA; Bansal N; Singla V; Khare S; Srivastava A
Diabetes Metab Syndr; 2020; 14(4):535-545. PubMed ID: 32408118
[TBL] [Abstract][Full Text] [Related]
7. Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events.
Nandy K; Salunke A; Pathak SK; Pandey A; Doctor C; Puj K; Sharma M; Jain A; Warikoo V
Diabetes Metab Syndr; 2020; 14(5):1017-1025. PubMed ID: 32634716
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme 2 as a versatile player in the management of coronavirus disease 2019.
Amano T
J Diabetes Investig; 2020 Sep; 11(5):1120-1122. PubMed ID: 32657484
[No Abstract] [Full Text] [Related]
9. Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis.
Schlesinger S; Neuenschwander M; Lang A; Pafili K; Kuss O; Herder C; Roden M
Diabetologia; 2021 Jul; 64(7):1480-1491. PubMed ID: 33907860
[TBL] [Abstract][Full Text] [Related]
10. Impact of diabetes mellitus on in-hospital mortality in adult patients with COVID-19: a systematic review and meta-analysis.
Kaminska H; Szarpak L; Kosior D; Wieczorek W; Szarpak A; Al-Jeabory M; Gawel W; Gasecka A; Jaguszewski MJ; Jarosz-Chobot P
Acta Diabetol; 2021 Aug; 58(8):1101-1110. PubMed ID: 33778910
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2.
Elamari S; Motaib I; Zbiri S; Elaidaoui K; Chadli A; Elkettani C
Pan Afr Med J; 2020; 37():32. PubMed ID: 33209159
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course.
Landstra CP; de Koning EJP
Front Endocrinol (Lausanne); 2021; 12():649525. PubMed ID: 34220706
[TBL] [Abstract][Full Text] [Related]
13. Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City.
Park BE; Lee JH; Park HK; Kim HN; Jang SY; Bae MH; Yang DH; Park HS; Cho Y; Lee BY; Nam CW; Lee JB; Kim U; Chae SC;
J Korean Med Sci; 2021 Jan; 36(2):e15. PubMed ID: 33429474
[TBL] [Abstract][Full Text] [Related]
14. Impact of cardiovascular and metabolic diseases on the severity of COVID-19: a systematic review and meta-analysis.
Meng M; Zhao Q; Kumar R; Bai C; Deng Y; Wan B
Aging (Albany NY); 2020 Nov; 12(22):23409-23421. PubMed ID: 33199670
[TBL] [Abstract][Full Text] [Related]
15. The Centrality of Obesity in the Course of Severe COVID-19.
Liu D; Zhang T; Wang Y; Xia L
Front Endocrinol (Lausanne); 2021; 12():620566. PubMed ID: 33776917
[TBL] [Abstract][Full Text] [Related]
16. Impaired Fasting Glucose and Diabetes Are Related to Higher Risks of Complications and Mortality Among Patients With Coronavirus Disease 2019.
Zhang J; Kong W; Xia P; Xu Y; Li L; Li Q; Yang L; Wei Q; Wang H; Li H; Zheng J; Sun H; Xia W; Liu G; Zhong X; Qiu K; Li Y; Wang H; Wang Y; Song X; Liu H; Xiong S; Liu Y; Cui Z; Hu Y; Chen L; Pan A; Zeng T
Front Endocrinol (Lausanne); 2020; 11():525. PubMed ID: 32754119
[No Abstract] [Full Text] [Related]
17. Hypertension is a clinically important risk factor for critical illness and mortality in COVID-19: A meta-analysis.
Du Y; Zhou N; Zha W; Lv Y
Nutr Metab Cardiovasc Dis; 2021 Mar; 31(3):745-755. PubMed ID: 33549450
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis.
Qiu P; Zhou Y; Wang F; Wang H; Zhang M; Pan X; Zhao Q; Liu J
Aging Clin Exp Res; 2020 Sep; 32(9):1869-1878. PubMed ID: 32734576
[TBL] [Abstract][Full Text] [Related]
19. Dipeptidyl peptidase-4 (DPP-4) inhibitor and mortality in coronavirus disease 2019 (COVID-19) - A systematic review, meta-analysis, and meta-regression.
Rakhmat II; Kusmala YY; Handayani DR; Juliastuti H; Nawangsih EN; Wibowo A; Lim MA; Pranata R
Diabetes Metab Syndr; 2021; 15(3):777-782. PubMed ID: 33838614
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients.
Dorjee K; Kim H; Bonomo E; Dolma R
PLoS One; 2020; 15(12):e0243191. PubMed ID: 33284825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
